The Microdose Program utilizes up to 0.6mg per week of GLP-1 and is designed for weight loss specifically
Interestingly, semaglutide (the active ingredient in Ozempic) is not processed this way
Even with lower prices, there is little evidence to date to suggest that the expanded use of GLP-1s will be offset by lower spending on other health care services in the short term, even though the drugs do provide significant health benefits to users
Choosing the best weight loss medication involves evaluating individual health needs, potential side effects, and desired outcomes
Note: Ozempic , Mounjaro , Victoza , and metformin are not FDA-approved to treat obesity or for weight loss
Alkem has received approval from the Drug Controller General of India (DCGI) for manufacturing and marketing semaglutide for type 2 diabetes mellitus and chronic weight management as an adjunct to diet and exercise, subsequent to a review of its Phase 3 clinical trials conducted in India